I. Judson

Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity.

Hilary Calvert, I. Judson, W J van der Vijgh · PubMed · 1993 · 80 citations

Therapeutic Activity, Pharmacotherapy, Metronomic Chemotherapy +19

Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancer.

D C Talbot, Ian E. Smith, Janine Mansi et al. · Journal of Clinical Oncology · 1991 · 62 citations

World Health Organization, Breast Oncology, Cancer Management +17

A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer

TJ Powles, A.L Jones, I. Judson et al. · British Journal of Cancer · 1991 · 34 citations · Full text

Advanced Breast Cancer, Breast Oncology, Oncology +9

The contemporary drug development process: advances and challenges in preclinical and clinical development.

Garrett Garrett, I. Judson, Paul Workman · PubMed · 2003 · 26 citations

Preclinical Therapeutics, Pharmaceutical Research, Drug Target +20

Metabolites of 2'-fluoro-2'-deoxy-D-glucose detected by 19F magnetic resonance spectroscopy in vivo predict response of murine RIF-1 tumors to 5-fluorouracil.

Paul M.J. McSheehy, Martin O. Leach, I. Judson et al. · PubMed · 2000 · 25 citations

Oncologic Imaging, Tumor Biology, Endocrine Oncology +17